Loading...
A Review of Three New Anti-interleukin-5 Monoclonal Antibody Therapies for Severe Asthma
Asthma is a chronic respiratory condition that is characterized by reversible airflow obstruction. Interleukin-5 (IL-5) is involved in the pathophysiology of the disease and drugs targeting IL-5 have been studied for years as a possible treatment option for severe asthma. In this review, the authors...
Na minha lista:
| Udgivet i: | Cureus |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Cureus
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6223665/ https://ncbi.nlm.nih.gov/pubmed/30416896 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.3216 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|